Furthermore, we found that ALKBH1 decreases the promoter’s 6 mA level of CDKN1A, thereby inhibiting the transcriptional expression of this tumor suppressor gene and exacerbating CRC. This evidence concerns the gene CDKN1A and colorectal carcinoma.